Positron emission tomography imaging in lymphoma Lenfomalarda pozitron emisyon tomografi görüntülemenin yeri


TÜRK H. M., Kalender M. E.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.16, sa.2, ss.108-113, 2006 (Scopus, TRDizin) identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 16 Sayı: 2
  • Basım Tarihi: 2006
  • Dergi Adı: UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.108-113
  • Anahtar Kelimeler: 18F-fluorodeoxyglucose positron emission tomography, Hodgkin's lymphoma, Non-Hodgkin's lymphoma
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

The role of 18F-fluorodeoxyglucose positron emission tomography in the staging of lymphoma, response to treatment and early diagnosis of relapses were evaluated in this review. 18F-fluorodeoxyglucose positron emission tomography is the best noninvasive screening method after treatment. However, the findings should be correlated with the clinical data, other radiological methods and biopsy. 18F-fluorodeoxyglucose positron emission tomography is superior to conventional radiological methods in the initial evoluation of Hodgkin lymphoma. 18F-fluorodeoxyglucose positron emission tomography when combined with computed tomography has advantages to both of the separate methods. 18F- fluorodeoxyglucose positron emission tomography is also benecial in defining the radiotherapy area and the planning of the surgical biopsy. Moreover, 18F-fluorodeoxyglucose positron emission tomography is found to be superior to galyum 67 in the literature.